Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 59, Number 12, December 24, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutschmann, O. T.
Right arrow Articles by Matchar, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutschmann, O. T.
Right arrow Articles by Matchar, D. B.
Related Collections
Right arrow All Demyelinating disease (CNS)
Right arrow Multiple sclerosis

Immunization and MS

A summary of published evidence and recommendations

Olivier T. Rutschmann, MD MPH, Douglas C. McCrory, MD MHSc and David B. Matchar, MD the Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines*

*See the Appendix on page 1843 for a list of Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines’ members.
From the Duke Center for Clinical Health Policy Research (Dr. Matchar), Duke University Medical Center, Durham, NC.



View larger version (24K):

[in a new window]
  		Figure. Differences in exacerbation and influenza rates after vaccine or placebo.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.